Literature DB >> 7907172

In situ hybridization study of kappa-opioid receptor mRNA in the rat brain.

M Minami1, Y Hosoi, T Toya, Y Katao, K Maekawa, S Katsumata, K Yabuuchi, T Onogi, M Satoh.   

Abstract

Distribution of kappa-opioid receptor mRNA in rat brain was examined by in situ hybridization technique. kappa-Opioid receptor mRNA was expressed in various brain regions, especially intensely in the neocortex (layer V and VI), caudate-putamen, nucleus accumbens, preoptic area, paraventricular thalamic nucleus, amygdala, several nuclei of hypothalamus, ventral tegmental area and substantia nigra pars compacta.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7907172     DOI： 10.1016/0304-3940(93)90585-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  8 in total

1.  Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  S D Schlussman; J Cassin; Y Zhang; O Levran; A Ho; M J Kreek
Journal:  Pharmacol Biochem Behav       Date:  2011-07-23       Impact factor: 3.533

2.  Further studies on possible dynorphin involvement in the ovulatory luteinizing hormone surge in the proestrous rat.

Authors:  Qiang Zhang; Jennifer M McCoy; Robert V Gallo
Journal:  Endocrine       Date:  2002-08       Impact factor: 3.633

3.  Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine prevention.

Authors:  Jennifer Y Xie; Milena De Felice; Caroline M Kopruszinski; Nathan Eyde; Justin LaVigne; Bethany Remeniuk; Pablo Hernandez; Xu Yue; Naomi Goshima; Michael Ossipov; Tamara King; John M Streicher; Edita Navratilova; David Dodick; Hugh Rosen; Ed Roberts; Frank Porreca
Journal:  Cephalalgia       Date:  2017-04-04       Impact factor: 6.292

4.  Opioidergic projections to sleep-active neurons in the ventrolateral preoptic nucleus.

Authors:  Mary-Ann Greco; Patrick M Fuller; Thomas C Jhou; S Martin-Schild; James E Zadina; Zhian Hu; Priyattam Shiromani; Jun Lu
Journal:  Brain Res       Date:  2008-09-24       Impact factor: 3.252

5.  Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats.

Authors:  Melissa L Perreault; Dawn Graham; Sarah Scattolon; Yufang Wang; Henry Szechtman; Jane A Foster
Journal:  Psychopharmacology (Berl)       Date:  2007-07-10       Impact factor: 4.530

6.  Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.

Authors:  A M W Taylor; K W Roberts; A A Pradhan; H A Akbari; W Walwyn; K Lutfy; F I Carroll; C M Cahill; C J Evans
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 7.  Direct hypothalamic and indirect trans-pallidal, trans-thalamic, or trans-septal control of accumbens signaling and their roles in food intake.

Authors:  Kevin R Urstadt; B Glenn Stanley
Journal:  Front Syst Neurosci       Date:  2015-02-13

8.  Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain.

Authors:  Joanna Mika; Katarzyna Popiolek-Barczyk; Ewelina Rojewska; Wioletta Makuch; Katarzyna Starowicz; Barbara Przewlocka
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.